AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Andrews, JL Kadan, MJ Gorziglia, MI Kaleko, M Connelly, S
Citation: Jl. Andrews et al., Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII, MOL THER, 3(3), 2001, pp. 329-336

Authors: Bristol, JA Gallo-Penn, A Andrews, J Idamakanti, N Kaleko, M Connelly, S
Citation: Ja. Bristol et al., Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia a mice compared with factor VIII protein infusion, HUM GENE TH, 12(13), 2001, pp. 1651-1661

Authors: Slosberg, ED Desai, UJ Fanelli, B Denny, IS Connelly, S Kaleko, M Boettcher, BR Caplan, SL
Citation: Ed. Slosberg et al., Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein, DIABETES, 50(8), 2001, pp. 1813-1820

Authors: Desai, UJ Slosberg, ED Boettcher, BR Caplan, SL Fanelli, B Stephan, Z Gunther, VJ Kaleko, M Connelly, S
Citation: Uj. Desai et al., Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression, DIABETES, 50(10), 2001, pp. 2287-2295

Authors: Gallo-Penn, AM Shirley, PS Andrews, JL Tinlin, S Webster, S Cameron, C Hough, C Notley, C Lillicrap, D Kaleko, M Connelly, S
Citation: Am. Gallo-penn et al., Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs, BLOOD, 97(1), 2001, pp. 107-113

Authors: Bristol, JA Shirley, P Idamakanti, N Kaleko, M Connelly, S
Citation: Ja. Bristol et al., In vivo dose threshold effect of adenovirus-mediated Factor VIII cone therapy in hemophiliac mice, MOL THER, 2(3), 2000, pp. 223-232

Authors: Roy, S Shirley, PS Connelly, S Andrews, JL Kayda, DB Gardner, JM Kaleko, M
Citation: S. Roy et al., In vivo evaluation of a novel epitope-tagged human factor VIII-encoding adenoviral vector, HAEMOPHILIA, 5(5), 1999, pp. 340-348

Authors: Andrews, JL Weaver, L Kaleko, M Connelly, S
Citation: Jl. Andrews et al., Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes, HAEMOPHILIA, 5(3), 1999, pp. 160-168

Authors: Gallo-Penn, AM Shirley, PS Andrews, JL Kayda, DB Pinkstaff, AM Kaloss, M Tinlin, S Cameron, C Notley, C Hough, C Lillicrap, D Kaleko, M Connelly, S
Citation: Am. Gallo-penn et al., In vivo evaluation of an adenoviral vector encoding canine factor VIII: High-level, sustained expression in hemophiliac mice, HUM GENE TH, 10(11), 1999, pp. 1791-1802

Authors: Connelly, S Andrews, JL Gallo-Penn, AM Tagliavacca, L Kaufman, RJ Kaleko, M
Citation: S. Connelly et al., Evaluation of an adenoviral vector encoding full-length human factor VIII in hemophiliac mice, THROMB HAEM, 81(2), 1999, pp. 234-239

Authors: Connelly, S
Citation: S. Connelly, Redefining Shakespeare: Literary theory and theater practice in the GermanDemocratic Republic, THEAT SURV, 40(2), 1999, pp. 117-119

Authors: Connelly, S
Citation: S. Connelly, Brecht's out-of-town tryout: The world premier of The 'Caucasian chalk circle', THEAT HIS S, 17, 1997, pp. 93-119
Risultati: 1-12 |